Intellia Therapeutics, Inc. (NTLA) vs Xencor, Inc. (XNCR)
Intellia Therapeutics, Inc. and Xencor, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Xencor, Inc. are of similar size ($1.8B and $1.7B). Intellia Therapeutics, Inc. grew revenue faster over the last twelve months: 12.6% against −28.6%. Xencor, Inc. has the higher net margin (−155.6% vs −672.2%) and the lower return on invested capital (−288.7% vs −91.3%). Across the 16 metrics below, Xencor, Inc. leads on 10 and Intellia Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | NTLA | XNCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (711.66%) | (205.84%) | 0.00% |
| Net margin | (672.16%) | (155.59%) | 0.00% |
| Free cash flow margin | (585.82%) | (198.42%) | 0.00% |
| Return on equity | (55.44%) | (29.07%) | (57.72%) |
| Return on assets | (45.55%) | (20.36%) | (49.22%) |
| Return on invested capital | (91.28%) | (288.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack